Dr Ngozi Elumongo has been appointed as a senior research fellow where she will supervise the research focusing on Faecal Microbiota Transplants (FMT) and their role in restoring healthy gut bacteria in patients who have suffered recurrent Clostridium difficile (C.diff) infections.
The treatment is revolutionary due to the fact it is a natural product and patients tolerate it with little to no side effects.
Dr Elumogo said: “This is an exciting new collaborative role. I’ll be there to act as a bridge between clinicians and researchers and will be asking the appropriate clinical questions to scientists to ensure that clinical practice and patient care are at the forefront of our research work.”
The Quadram Institute will be at the forefront of combined research into food science, gut biology and health. The building will house a range of endoscopy and bowel cancer screening services run by NNUH, a Clinical Research Facility, and world-leading food and health scientists. Having clinical expertise alongside academic research will drive the translation of new knowledge into evidence-based strategies to maximise health and reduce the impact of disease and infection.